Paper41769263
Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis.
Pan Z and 5 others. Drug Des Devel Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis. Papers, record 41769263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41769263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrosis | Major topic |
| Antifibrotic Agents | Major topic |
| Humans | |
| Animals | |
| Kidney |
Source PubMed
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36864460 | Epigenetics as a versatile regulator of fibrosis. | J Transl Med | 2023 | https://conductscience.org/library/papers/36864460 | PubMed |
| 2 | 31852635 | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. | Lancet Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31852635 | PubMed |
| 3 | 37027478 | Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. | Sci Immunol | 2023 | https://conductscience.org/library/papers/37027478 | PubMed |
| 4 | 28073888 | Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. | Gut | 2017 | https://conductscience.org/library/papers/28073888 | PubMed |
| 5 | 31718044 | TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. | Cells | 2019 | https://conductscience.org/library/papers/31718044 | PubMed |
| 6 | 33015415 | Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition. | JACC Basic Transl Sci | 2020 | https://conductscience.org/library/papers/33015415 | PubMed |
| 7 | 39209202 | Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/39209202 | PubMed |
| 8 | 29427496 | Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. | Liver Int | 2018 | https://conductscience.org/library/papers/29427496 | PubMed |
| 9 | 26676815 | Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution. | Semin Liver Dis | 2015 | https://conductscience.org/library/papers/26676815 | PubMed |
| 10 | 33301464 | Joint influences of obesity, diabetes, and hypertension on indices of ventricular remodeling: Findings from the community-based Framingham Heart Study. | PLoS One | 2020 | https://conductscience.org/library/papers/33301464 | PubMed |
| 11 | 31944822 | Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis. | Am J Respir Cell Mol Biol | 2020 | https://conductscience.org/library/papers/31944822 | PubMed |
| 12 | 36473860 | A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. | Nat Commun | 2022 | https://conductscience.org/library/papers/36473860 | PubMed |
| 13 | 41053127 | Rho-kinase inhibition reduces subretinal fibrosis. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41053127 | PubMed |
| 14 | 29532104 | Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants. | Eur J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29532104 | PubMed |
| 15 | 31122893 | Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. | Lancet Respir Med | 2019 | https://conductscience.org/library/papers/31122893 | PubMed |
| 16 | 39925851 | Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: a descriptive analysis of the WHO-VigiAccess database. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39925851 | PubMed |
| 17 | 34297930 | Fibroblasts: Origins, definitions, and functions in health and disease. | Cell | 2021 | https://conductscience.org/library/papers/34297930 | PubMed |
| 18 | 35830489 | Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis. | Am J Respir Crit Care Med | 2022 | https://conductscience.org/library/papers/35830489 | PubMed |
| 19 | 37013673 | Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non-Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study. | J Magn Reson Imaging | 2024 | https://conductscience.org/library/papers/37013673 | PubMed |
| 20 | 40183479 | Underrepresentation of Arabs in Functional Genetics Studies: Opportunities and Obstacles for Advancing Biology and Human Health. | Liver Int | 2025 | https://conductscience.org/library/papers/40183479 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42861230 | Antifibrotics with Cross-Indication Potential: Challenges and Progress Towards a Universal Fibrosis-Modifying Therapy. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42861230 |
Source PubMed
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41769263
GET https://conductscience.org/api/papers/v1/41769263/references?page=2